Bio-Path Holdings (BPTH) Reports Q3 Loss of $0.02/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Bio-Path Holdings (BPTH) Reports Q3 Loss of $0.02/Share

Bio-Path Holdings Reports Third Quarter 2015 Operational and Financial Results

November 10, 2015 8:55 AM EST

HOUSTON--(BUSINESS WIRE)-- Bio-Path Holdings, Inc., (NASDAQ: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize liposomal delivery technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced operational and financial results for the quarter ended September 30, 2015.

The third quarter of 2015 proved to be an exciting time for Bio-Path, as we made significant progress with our lead product candidate, BP1001, said Peter Nielsen, President and Chief Executive Officer of Bio-Path. We reported that one patient with advanced acute myeloid leukemia in our Phase Ib trial achieved complete remission, and another patient... More